Impact Factor
3.65
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.37
501 total citations
h5-index
27
h5 depth signal
Cited share
85.0%
102 of 120
Total citations
501
Citation footprint
Metric signal
3.44
External metric anchor
Self-citation
4.0%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
394
United States
262
Japan
89
Canada
39
United Kingdom
28
Citing Fields of Research
Anesthetic & Pain Medicine
623
Physiology
189
Nervous System Disorders
97
Musculoskeletal Disorders
90
Neurosciences
82
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,664
Articles tracked across the journal lifetime
Indexed publication set
120
102 cited publications
Last 12 months
87
8.7 publications/month
Open access share
100.0%
87 OA publications in the last year
Leading citing country
China
394 citing publications
Leading citing field
Anesthetic & Pain Medicine
623 citing publications
Latest tracked publication
15 July 2026
10 recent records available
Coverage & Indexing History
v1, 2005-
v1, 2005-
Active Coverage
Research Focus & Classification
Indexed Subjects
Anesthetic & Pain Medicine
Broad Categories
Molecular Biology
Neurology
Psychophysiology
Anesthetic & Pain Medicine
MeSH Descriptors
Pain
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/17448069261468209
Open DOI
Bradykinin B2 Receptor Triggers ITPR1-Mediated ER Calcium Release in Trigeminal Ganglion Neurons to Drive Trigeminal Neuropathic Pain.
To elucidate the role and underlying mechanism of bradykinin (BK) B2 receptor and its downstream inositol 1,4,5-trisphosphate receptor type 1 (ITPR1)-mediated endoplasmic reticulum (ER) calcium release signaling in the development and ma...
02
DOI 10.1177/17448069261466889
Open DOI
Pain and Inflammatory Biomarkers: Phytoactive Therapeutics and Drug Delivery Advances.
Pain and inflammation are complex physiological processes involving multiple molecular interactions and cellular responses. Biomarkers such as cytokines, neuropeptides, oxidative stress markers, and genetic polymorphisms have become valu...
03
04
DOI 10.1177/17448069261463365
Open DOI
Effects of cooling on the excitability of trigeminal Aβ-afferent nociceptors in mice: Involvement of temperature-sensitive K2P channels
Aβ-afferents are traditionally believed to be low-threshold mechanoreceptors (LTMRs) involved in sensing innocuous mechanical stimuli such as gentle touch; however, emerging evidence indicates that a subset of Aβ-afferents functions as h...
05
DOI 10.1177/17448069261455315
Open DOI
A life in pain research: The scientific legacy of Howard L. Fields
06
DOI 10.1177/17448069261461222
Open DOI
EXPRESS: Assessing Pain Sensitivity with COX-2 Biomarkers: A Novel Approach in Healthy Volunteers
Quantifying pain is challenging due to its subjective nature. An established baseline of COX-2 levels in healthy subjects under controlled thermal pain stimulation will help bridge subjective pain assessment and objective biological meas...
07
DOI 10.1177/17448069261460644
Open DOI
Stimulation of spinal afferents from skin activates parabrachial neurons that respond to taste
The parabrachial (PB) nucleus participates in neural coding for diverse sensory modalities, including nociception and taste. Recent neurophysiological studies identified a subpopulation of PB neurons that responds to both gustatory and o...
08
DOI 10.1177/17448069261460645
Open DOI
EXPRESS: Precursor signaling redefined: proneurotrophin-3, not neurotrophin-3, in primary sensory neurons as an instigator in neuropathic pain
Neurotrophin-3 (NT3), one member of the nerve growth factor family of neurotrophins, is initially synthesized as a large precursor, termed proneurotrophin-3 (proNT3), which undergoes proteolytic cleavage to generate mature NT3. A growing...
09
DOI 10.1177/17448069261460286
Open DOI
Dezocine alleviates cancer-induced bone pain and suppresses intraosseous tumor growth in renal cell carcinoma via the NAMPT/NAD+ axis
Bone metastasis–associated pain is a major cause of morbidity in advanced renal cell carcinoma (RCC), and effective therapies that concurrently mitigate pain and intraosseous tumor burden remain limited. Here, we evaluated dezocine as a ...
10
DOI 10.1177/17448069261459255
Open DOI
EXPRESS: Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment
Background: This study aimed to explore potential biomarkers and mechanisms underlying in the treatment of neuropathic pain(NP) with Fu's subcutaneous needling(FSN), employing a transcriptomics approach. Methods: In this study, RNA seque...
Bibliographical & Catalog Notes
Title from PDF caption (publisher Web site, viewed Mar. 22, 2005).
Latest issue consulted: 1:10 (22 Mar. 2005) (viewed Mar. 22, 2005).
Articles published individually, then compiled into an annual vol.
Mode of access: World Wide Web; may require Adobe Acrobat Reader.